Video
Dr. Gomella highlights his NYU GU 2022 presentations on bladder and prostate cancer
Author(s):
“The fascinating thing is that we have so many new treatments that are now available to us,” says Leonard G. Gomella, MD, FACS.
Video Player is loading.
In this video, Leonard G. Gomella, MD, FACS, discusses key points from his 2 presentations, “Monitoring and Diagnosis of Non—Muscle-Invasive Bladder Cancer,” and “The Evolution of Biomarkers and Genetics in the Management of Prostate Cancer,” which were given at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Gomella is the Bernard W. Godwin Professor of Prostate Cancer, chair of urology, and senior director for clinical affairs, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania.
Related Videos
Expert discusses the NMIBC trials landscape
John Gore, MD, on bladder preservation in muscle–invasive bladder cancer
Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
Joshua J. Meeks, MD, PhD, discusses NIAGARA data for patient undergoing cystectomy
Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
Study data point to gender disparities in oncology research citations
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscape
Expert describes implications of neoadjuvant durvalumab approval in MIBC
Sima Porten, MD, on gene-environment interactions in bladder cancer development
Related Content
